{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:36:48Z","timestamp":1774129008685,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00228-013-1560-2","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T17:55:10Z","timestamp":1374688510000},"page":"1973-1979","source":"Crossref","is-referenced-by-count":14,"title":["Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment"],"prefix":"10.1007","volume":"69","author":[{"given":"Teresa M.","family":"Salgado","sequence":"first","affiliation":[]},{"given":"Blanca","family":"Arguello","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Martinez-Martinez","sequence":"additional","affiliation":[]},{"given":"Shalom I.","family":"Benrimoj","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"issue":"15","key":"1560_CR1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200\u20131205","journal-title":"JAMA"},{"issue":"12","key":"1560_CR2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.163.12.1409","volume":"163","author":"R Kaushal","year":"2003","unstructured":"Kaushal R, Shojania KG, Bates DW (2003) Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 163(12):1409\u20131416","journal-title":"Arch Intern Med"},{"key":"1560_CR3","first-page":"1207","volume":"2011","author":"K Saxena","year":"2011","unstructured":"Saxena K, Lung BR, Becker JR (2011) Improving patient safety by modifying provider ordering behavior using alerts (CDSS) in CPOE system. AMIA Annu Symp Proc 2011:1207\u20131216","journal-title":"AMIA Annu Symp Proc"},{"issue":"10","key":"1560_CR4","first-page":"509","volume":"27","author":"GJ Kuperman","year":"2001","unstructured":"Kuperman GJ, Teich JM, Gandhi TK, Bates DW (2001) Patient safety and computerized medication ordering at Brigham and Women\u2019s Hospital. Jt Comm J Qual Improv 27(10):509\u2013521","journal-title":"Jt Comm J Qual Improv"},{"key":"1560_CR5","volume-title":"Making health care safer: a critical analysis of patient safety practices","author":"R Kaushal","year":"2001","unstructured":"Kaushal R, Bates DW (2001) Chapter 6. Computerized physician order entry (CPOE) with clinical decision support systems (CDSSs). In: Shojania KG, Duncan BW, McDonald KM, Wachter RM (eds) Making health care safer: a critical analysis of patient safety practices. AHRQ, Rockville"},{"issue":"7","key":"1560_CR6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archinte.164.7.785","volume":"164","author":"A Bobb","year":"2004","unstructured":"Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA (2004) The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med 164(7):785\u2013792","journal-title":"Arch Intern Med"},{"issue":"15","key":"1560_CR7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jama.280.15.1311","volume":"280","author":"DW Bates","year":"1998","unstructured":"Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, Burdick E, Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger DL (1998) Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. Jama 280(15):1311\u20131316","journal-title":"Jama"},{"issue":"1","key":"1560_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2125.2011.03981.x","volume":"73","author":"S Maxwell","year":"2012","unstructured":"Maxwell S, Eichler HG, Bucsics A, Haefeli WE, Gustafsson LL (2012) e-SPC\u2014delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers. Br J Clin Pharmacol 73(1):12\u201315","journal-title":"Br J Clin Pharmacol"},{"key":"1560_CR9","unstructured":"European Commission (2009) Notice to Applicants. A guideline on Summary of Product Characteristics (SmPC). Available at: http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-2\/c\/smpc_guideline_rev2_en.pdf Accessed 25-May-2011"},{"key":"1560_CR10","unstructured":"European Medicines Agency (2013) How to prepare and review a Summary of Product Characteristics. Available at: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/document_listing\/document_listing_000357.jsp&mid=WC0b01ac05806361e1 . Accessed 04-May-2013"},{"issue":"2","key":"1560_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00228-004-0846-9","volume":"61","author":"MT San Miguel","year":"2005","unstructured":"San Miguel MT, Martinez JA, Vargas E (2005) Food-drug interactions in the summary of product characteristics of proprietary medicinal products. Eur J Clin Pharmacol 61(2):77\u201383","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1560_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11096-004-1733-2","volume":"27","author":"I Fusier","year":"2005","unstructured":"Fusier I, Tollier C, Husson MC (2005) Infovigilance: reporting errors in official drug information sources. Pharm World Sci 27(3):166\u2013169","journal-title":"Pharm World Sci"},{"issue":"4","key":"1560_CR13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2125.2005.02440.x","volume":"60","author":"RE Ferner","year":"2005","unstructured":"Ferner RE, Coleman J, Pirmohamed M, Constable SA, Rouse A (2005) The quality of information on monitoring for haematological adverse drug reactions. Br J Clin Pharmacol 60(4):448\u2013451","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1560_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/106002809302700418","volume":"27","author":"SL Pestotnik","year":"1993","unstructured":"Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP (1993) Prospective surveillance of imipenem\/cilastatin use and associated seizures using a hospital information system. Ann Pharmacother 27(4):497\u2013501","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1560_CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0002-9343(77)90406-5","volume":"62","author":"H Jick","year":"1977","unstructured":"Jick H (1977) Adverse drug effects in relation to renal function. Am J Med 62(4):514\u2013517","journal-title":"Am J Med"},{"issue":"11","key":"1560_CR16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00228-004-0852-y","volume":"60","author":"M Martin-Facklam","year":"2005","unstructured":"Martin-Facklam M, Rengelshausen J, Tayrouz Y, Ketabi-Kiyanvash N, Lindenmaier H, Schneider V, Bergk V, Haefeli WE (2005) Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? Eur J Clin Pharmacol 60(11):807\u2013811","journal-title":"Eur J Clin Pharmacol"},{"issue":"1\u20132","key":"1560_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1445-5994.2003.00330.x","volume":"33","author":"PI Pillans","year":"2003","unstructured":"Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM (2003) Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 33(1\u20132):10\u201313","journal-title":"Intern Med J"},{"key":"1560_CR18","doi-asserted-by":"crossref","unstructured":"Bertsche T, Fleischer M, Pfaff J, Encke J, Czock D, Haefeli WE (2009) Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency. Eur J Clin Pharmacol","DOI":"10.1007\/s00228-009-0643-6"},{"issue":"3","key":"1560_CR19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jamia.2009.001537","volume":"17","author":"GW Roberts","year":"2010","unstructured":"Roberts GW, Farmer CJ, Cheney PC, Govis SM, Belcher TW, Walsh SA, Adams RJ (2010) Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inform Assoc 17(3):308\u2013312","journal-title":"J Am Med Inform Assoc"},{"issue":"22","key":"1560_CR20","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.286.22.2839","volume":"286","author":"GM Chertow","year":"2001","unstructured":"Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, Lee R, Mekala A, Song J, Komaroff AL, Bates DW (2001) Guided medication dosing for inpatients with renal insufficiency. JAMA 286(22):2839\u20132844","journal-title":"JAMA"},{"issue":"June","key":"1560_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5414\/CP201678","volume":"50","author":"HY Wang","year":"2012","unstructured":"Wang HY, Lu CL, Wu MP, Huang MH, Huang YB (2012) Effectiveness of an integrated CPOE decision supporting system with clinical pharmacist monitoring practice in preventing antibiotic dosing errors. Int J Clin Pharmacol Ther 50(June):375\u2013382","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"1560_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2710.2011.01310.x","volume":"37","author":"JJ Coleman","year":"2012","unstructured":"Coleman JJ, Nwulu U, Ferner RE (2012) Decision support for sensible dosing in electronic prescribing systems. J Clin Pharm Ther 37(4):415\u2013419","journal-title":"J Clin Pharm Ther"},{"key":"1560_CR23","doi-asserted-by":"crossref","unstructured":"Dowling TC, Wang ES, Ferrucci L, Sorkin JD (2013) Glomerular filtration rate equations overestimate creatinine clearance in older individuals enrolled in the Baltimore longitudinal study on aging: impact on renal drug dosing. Pharmacotherapy. doi: 10.1002\/phar.1282","DOI":"10.1002\/phar.1282"},{"issue":"3","key":"1560_CR24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ptj\/85.3.257","volume":"85","author":"J Sim","year":"2005","unstructured":"Sim J, Wright CC (2005) The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 85(3):257\u2013268","journal-title":"Phys Ther"},{"issue":"1","key":"1560_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174","journal-title":"Biometrics"},{"issue":"1","key":"1560_CR26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mcp.2003.20","volume":"73","author":"A Rajpal","year":"2003","unstructured":"Rajpal A, Reidenberg MM (2003) Drug labeling should be kept current. Clin Pharmacol Ther 73(1):4\u20136","journal-title":"Clin Pharmacol Ther"},{"key":"1560_CR27","unstructured":"European Medicines Agency (2007) Orphan drugs and rare diseases at a glance. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2010\/01\/WC500069805.pdf . Accessed 16 Apr 2013"},{"issue":"22","key":"1560_CR28","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1001\/jama.2011.769","volume":"305","author":"AS Kesselheim","year":"2011","unstructured":"Kesselheim AS, Myers JA, Avorn J (2011) Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer. Jama 305(22):2320\u20132326","journal-title":"Jama"},{"issue":"4","key":"1560_CR29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00228-012-1423-2","volume":"69","author":"R Joppi","year":"2013","unstructured":"Joppi R, Bertele V, Garattini S (2013) Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU Eur J Clin Pharmacol 69(4):1009\u20131024","journal-title":"The first decade of orphan drug legislation in the EU. Eur J Clin Pharmacol"},{"key":"1560_CR30","unstructured":"European Medicines Agency (2004) Note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003123.pdf . Accessed 11 Feb 2013"},{"key":"1560_CR31","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (2010) Guidance for industry: pharmacokinetics in patients with impaired renal function\u2014study design, data analysis and impact on dosing and labeling. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM204959.pdf . Accessed 08 Dec 2012"},{"issue":"3","key":"1560_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pds.3389","volume":"22","author":"B Pfistermeister","year":"2013","unstructured":"Pfistermeister B, Schenk C, Kornhuber J, Burkle T, Fromm MF, Maas R (2013) Different indications, warnings and precautions, and contraindications for the same drug\u2013an international comparison of prescribing information for commonly used psychiatric drugs. Pharmacoepidemiol Drug Saf 22(3):329\u2013333","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1560_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00228-006-0229-5","volume":"63","author":"E Garbe","year":"2007","unstructured":"Garbe E, Andersohn F (2007) Contraindication labelling changes in the United States and Germany. Eur J Clin Pharmacol 63(1):87\u201393","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1560_CR34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.clpt.6100198","volume":"82","author":"B Arguello","year":"2007","unstructured":"Arguello B, Fernandez-Llimos F (2007) Clinical pharmacology information in summaries of product characteristics and package inserts. Clin Pharmacol Ther 82(5):566\u2013571","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1560_CR35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1472-8206.2010.00815.x","volume":"24","author":"M Rougemont","year":"2010","unstructured":"Rougemont M, Ulrich S, Hiemke C, Corruble E, Baumann P (2010) French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs. Fundam Clin Pharmacol 24(3):377\u2013384","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"1560_CR36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pds.3351","volume":"22","author":"J Duke","year":"2013","unstructured":"Duke J, Friedlin J, Li X (2013) Consistency in the safety labeling of bioequivalent medications. Pharmacoepidemiol Drug Saf 22(3):294\u2013301","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1560_CR37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2125.2008.03322.x","volume":"67","author":"AJ Wall","year":"2009","unstructured":"Wall AJ, Bateman DN, Waring WS (2009) Variability in the quality of overdose advice in Summary of Product Characteristics (SPC) documents: gut decontamination recommendations for CNS drugs. Br J Clin Pharmacol 67(1):83\u201387","journal-title":"Br J Clin Pharmacol"},{"key":"1560_CR38","first-page":"90","volume":"1","author":"F Fernandez-Llimos","year":"1999","unstructured":"Fernandez-Llimos F (1999) Information on drugs for the community pharmacy. Pharm Care Esp 1:90\u201396","journal-title":"Pharm Care Esp"},{"issue":"5\u20136","key":"1560_CR39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00228-005-0943-4","volume":"61","author":"V Bergk","year":"2005","unstructured":"Bergk V, Haefeli WE, Gasse C, Brenner H, Martin-Facklam M (2005) Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature. Eur J Clin Pharmacol 61(5\u20136):327\u2013335","journal-title":"Eur J Clin Pharmacol"},{"key":"1560_CR40","unstructured":"Salgado TM, Arguello B, Benrimoj SI, Fernandez-Llimos F (2012) Discordances in the classification of renal impairment in summaries of product characteristics. In: FIP Centennial Congress. Amsterdam"},{"issue":"1","key":"1560_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1\u2013150","journal-title":"Kidney Int Suppl"},{"issue":"8","key":"1560_CR42","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1515\/cclm-2011-0753","volume":"50","author":"AF Geerts","year":"2012","unstructured":"Geerts AF, De Koning FH, Van Solinge WW, De Smet PA, Egberts TC (2012) Instructions on laboratory monitoring in 200 drug labels. Clin Chem Lab Med 50(8):1351\u20131358","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"1560_CR43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2125.2011.04058.x","volume":"73","author":"PB Rahmner","year":"2012","unstructured":"Rahmner PB, Eiermann B, Korkmaz S, Gustafsson LL, Gruven M, Maxwell S, Eichle HG, Veg A (2012) Physicians\u2019 reported needs of drug information at point of care in Sweden. Br J Clin Pharmacol 73(1):115\u2013125","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1560_CR44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4321\/S1130-01082012000400002","volume":"104","author":"L Perianez-Parraga","year":"2012","unstructured":"Perianez-Parraga L, Martinez-Lopez I, Ventayol-Bosch P, Puigventos-Latorre F, Delgado-Sanchez O (2012) Drug dosage recommendations in patients with chronic liver disease. Rev Esp Enferm Dig 104(4):165\u2013184","journal-title":"Rev Esp Enferm Dig"},{"issue":"7511","key":"1560_CR45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.331.7511.293","volume":"331","author":"GK McEvoy","year":"2005","unstructured":"McEvoy GK (2005) Dose adjustment in renal impairment: response from AHFS Drug Information. BMJ 331(7511):293","journal-title":"BMJ"},{"issue":"18","key":"1560_CR46","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMp0907708","volume":"361","author":"LM Schwartz","year":"2009","unstructured":"Schwartz LM, Woloshin S (2009) Lost in transmission\u2013FDA drug information that never reaches clinicians. N Engl J Med 361(18):1717\u20131720","journal-title":"N Engl J Med"},{"issue":"7511","key":"1560_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmj.38476.471088.3A","volume":"331","author":"L Vidal","year":"2005","unstructured":"Vidal L, Shavit M, Fraser A, Paul M, Leibovici L (2005) Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 331(7511):263","journal-title":"BMJ"},{"issue":"12","key":"1560_CR48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00228-007-0370-9","volume":"63","author":"HM Seidling","year":"2007","unstructured":"Seidling HM, Al Barmawi A, Kaltschmidt J, Bertsche T, Pruszydlo MG, Haefeli WE (2007) Detection and prevention of prescriptions with excessive doses in electronic prescribing systems. Eur J Clin Pharmacol 63(12):1185\u20131192","journal-title":"Eur J Clin Pharmacol"},{"key":"1560_CR49","unstructured":"Payne TH, Nichol WP, Hoey P, Savarino J (2002) Characteristics and override rates of order checks in a practitioner order entry system. Proc AMIA Symp:602\u2013606"},{"issue":"2","key":"1560_CR50","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1197\/jamia.M1809","volume":"13","author":"H Sijs van der","year":"2006","unstructured":"van der Sijs H, Aarts J, Vulto A, Berg M (2006) Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13(2):138\u2013147","journal-title":"J Am Med Inform Assoc"},{"issue":"21","key":"1560_CR51","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1001\/archinte.163.21.2625","volume":"163","author":"SN Weingart","year":"2003","unstructured":"Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS (2003) Physicians\u2019 decisions to override computerized drug alerts in primary care. Arch Intern Med 163(21):2625\u20132631","journal-title":"Arch Intern Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-013-1560-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-013-1560-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-013-1560-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T15:38:31Z","timestamp":1596209911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-013-1560-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1007\/s00228-013-1560-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}